Objective:

To investigate the timeline and nature of antibody production in newborns compared to maternal antibody transfer.

Key Findings:

• At birth, infant serum was dominated by maternal IgG1, while IgA1 was nearly absent.
• By 7-11 weeks postpartum, infant serum contained new IgA1 and IgG1 antibodies that did not overlap with maternal sources.
• IgA1 detected in infant circulation is produced by the infant, not absorbed from breast milk.
• A significant fraction of new, infant-specific IgG1 clones appeared within the first two to three months of life.
• Milk IgA primarily acts at mucosal surfaces and does not enter the infant bloodstream.

Interpretation:

Infant antibody production begins earlier than previously thought, suggesting a rapid establishment of systemic humoral immunity independent of maternal antibodies.

Limitations:

• The study involved a small sample size of only four mother-infant pairs.
• Further research is needed to generalize findings across diverse populations.

Conclusion:

The findings have implications for understanding neonatal immune development and could influence future vaccination strategies.